362 results on '"Destache, Christopher J"'
Search Results
2. Assessment of the impact of centralized bioMérieux BACT/ALERT® VIRTUO® blood culture system (VIRTUO) implementation on outcomes in patients with gram-negative bacteremia
3. A comparison of clinical outcomes associated with dosing metronidazole every 8 hours versus every 12 hours: a systematic review and metaanalysis
4. 185. Pseudomonas aeruginosa (PA) Bacteremia and Patient Outcome during COVID-19 Pandemic
5. Effect of antimicrobial stewardship with rapid MALDI-TOF identification and Vitek 2 antimicrobial susceptibility testing on hospitalization outcome
6. Nanoencapsulation introduces long-acting phenomenon to tenofovir alafenamide and emtricitabine drug combination: A comparative pre-exposure prophylaxis efficacy study against HIV-1 vaginal transmission
7. A comparison of clinical outcomes associated with dosing metronidazole every 8 hours versus every 12 hours: a systematic review and metaanalysis.
8. Diagnosis and Outcomes of Fungal Co-Infections in COVID-19 Infections: A Retrospective Study
9. Sex and Race Disparities in Hepatocellular Carcinoma Surveillance in Patients With Chronic Hepatitis B During COVID-19: A Single-Center Retrospective Review
10. A Comparison of Clinical Outcomes Associated with Dosing Metronidazole Every 8 Hours Versus Every 12-Hours: A Systematic Review and Meta-Analysis
11. Pharmacokinetic and Tissue Distribution Profile of Long Acting Tenofovir Alafenamide and Elvitegravir Loaded Nanoparticles in Humanized Mice Model
12. Simultaneous quantification of tenofovir, emtricitabine, rilpivirine, elvitegravir and dolutegravir in mouse biological matrices by LC–MS/MS and its application to a pharmacokinetic study
13. Natural polyphenols: potential in the prevention of sexually transmitted viral infections
14. Correction to: Pharmacokinetic and Tissue Distribution Profile of Long Acting Tenofovir Alafenamide and Elvitegravir Loaded Nanoparticles in Humanized Mice Model
15. Structural Determinants of Indole-2-carboxamides: Identification of Lead Acetamides with Pan Antimycobacterial Activity
16. Assessing Appropriateness of Antimicrobial Therapy: In the Eye of the Interpreter
17. Breaking Down the Barriers: Challenges With Development and Implementation of an Industry-Sponsored Antimicrobial Stewardship Data Collection and Analysis Tool
18. Discovery of a non-nucleoside RNA polymerase inhibitor for blocking Zika virus replication through in silico screening
19. COVID-19 Mortality and Therapeutics in Nebraska and Southwest Iowa during Early Pandemic
20. Targeted Immuno-Antiretroviral to Promote Dual Protection against HIV: A Proof-of-Concept Study
21. A review of nanotechnological approaches for the prophylaxis of HIV/AIDS
22. Tenofovir alafenamide and elvitegravir loaded nanoparticles for long-acting prevention of HIV-1 vaginal transmission
23. Development and evaluation of a thermosensitive vaginal gel containing raltegravir + efavirenz loaded nanoparticles for HIV prophylaxis
24. Structural Determinants of Indole-2-carboxamides: Identification of Lead Acetamides with Pan Antimycobacterial Activity.
25. Improving understanding and utilization of the antibiogram among medical residents
26. Beta-Lactam vs. Fluoroquinolone Monotherapy for Pseudomonas aeruginosa Infection: A Systematic Review and Meta-Analysis
27. Teaching Heart Failure Treatment Guidelines and Assessing Heart Failure Therapy
28. A Survey of Pharmacy Students' Experiences With Gambling
29. Bamlanivimab use in mild‐to‐moderate COVID‐19 disease: A matched cohort design
30. Rotation Students' Perceptions of Clinical Workload Documentation Using a Personal Digital Assistant
31. Antimicrobial Treatment of Asymptomatic Bacteriuria in Noncatheterized Adults: A Systematic Review
32. Role of Prostanoid Production and Receptors in the Regulation of Retinal Endogenous Amino Acid Neurotransmitters by 8-Isoprostaglandin E2, Ex Vivo
33. A Concept Evaluation Study of a New Combination Bictegravir plus Tenofovir Alafenamide Nanoformulation with Prolonged Sustained-Drug-Release Potency for HIV-1 Preexposure Prophylaxis
34. Nanotechnology: A Focus on Nanoparticles as a Drug Delivery System
35. Bictegravir Plus Tenofovir Alafenamide Nanoformulation as a Long-Acting Pre-Exposure Prophylaxis Regimen: Application of Modeling to Design Non-Human Primate Pharmacokinetic Experiments
36. Antibacterials and Acute Exacerbation of Chronic Bronchitis: Issues for Formulary Decision Makers
37. Brain as an HIV sequestered site
38. Targeted immuno-antiretroviral HIV therapeutic approach to provide dual protection and boosts cellular immunity: A proof-of-concept study
39. Antiretroviral release from poly(DL-lactide-co-glycolide) nanoparticles in mice
40. Research Spotlight: Antiretroviral nanoparticles: an extended drug delivery modality
41. Implementation of a Health-System Wide Antimicrobial Stewardship Program in Omaha, NE
42. 2691. Comparison of Incidence and Mortality of Kaposi’s Sarcoma Amongst Solid-Organ Transplant Recipients
43. 2095. Antimicrobial Stewardship (ASP) in Rural and Critical Access Hospitals (CAHs) Using TeleStewardship® Services
44. 2501. CCR5 Targeted ARV Loaded Nanoparticle: Dual Protection for HIV Functional Cure
45. 2394. A Longitudinal Study of the Effect of Renal Failure on Readmission Rates of Patients with Clostridioides difficile
46. 1069. Implementation and Results of a Health-System Antimicrobial Stewardship (AMS) Program
47. Preprinted risk assessment and prophylaxis order form for venous thromboembolism
48. Cost Considerations in Therapeutic Drug Monitoring of Aminoglycosides
49. Economic Aspects of Pharmacokinetic Services
50. Impact of time to antibiotic administration on hospitalization length for community-acquired pneumonia.: 158.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.